1 terminated. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Terminated 1 |
| Phase 2 | 1 | Terminated 1 |
Follow Human Papillomavirus Infections: new trials by email Literature Review of Human Papillomavirus Infections trials Research Report on Human Papillomavirus Infections
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety, Reactogenicity and Immunogenicity of Adenovirus Serotype 26 (Ad26)- and Modified Vaccinia Ankara (MVA)-Vectored Vaccine Components in Otherwise Healthy Women With HPV16 or HPV18 Infection of the Cervix Ad26.HPV16, Ad26.HPV18, MVA.HPV16/18 - Human Papillomavirus Infections | Phase 1 / Phase 2 | Terminated | Janssen Vaccines & Prevention B.V. | 9 | 2018-09-27 | 2025-02-04 |
Communicable Diseases (1) · DNA Virus Infections (1) · Disease Attributes (1) · Genital Diseases (1) · Infections (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Sexually Transmitted Diseases (1) · Sexually Transmitted Diseases, Viral (1) · Tumor Virus Infections (1) · Urogenital Diseases (1) · Virus Diseases (1)
Janssen Vaccines & Prevention B.V. (1)
Belgium (1) · United States (1)
2018 (1)